The price of a batch of drugs is reduced by up to 85% (list attached)

A large number of varieties, take the initiative to reduce prices

On March 29, the Shaanxi Public Resources Trading Center announced that the price of other products such as Leuprolide Acetate Sustained-Release Microspheres for injection will be adjusted online.

The content of the notice shows that the prices of some medicines have dropped significantly.

1.

It can be seen from the enterprises' voluntarily applying for price reductions that the price adjustment of the unselected varieties of national centralized procurement is the general trend.

For example, for the second batch of national centralized procurement, the Shanghai Sunshine Pharmaceutical Purchasing Network previously issued the "Supplementary Documents for the National Centralized Procurement of Drugs in Shanghai", which detailed the use of selected drugs and the use of non-selected drugs.

In addition, the Gansu Provincial Drugs and Medical Consumables Centralized Procurement Network also issued the "Explanation on the Adjustment of Drug Prices Related to the Centralized Procurement of Drugs Organized by the State", which for the first time gave specific price reductions for unselected original drugs and generic drugs that passed the consistency evaluation.

With the continuous advancement of national centralized procurement, whether it is selected or not, price reduction has become an inevitable trend for centralized procurement.

2.

In recent years, with the rise of domestic innovative drugs, drug research and development has increased, and the monoclonal antibody market has seen a "blowout" trend.

In fact, the price reduction of monoclonal antibody drugs in the past two years is far more than Uselnumab.

It can be seen that under the superimposed effect of a series of policies, the downward adjustment of drug prices is a general trend.

Attachment: Product Price Adjustment Table (Shaanxi)